基本信息
views: 26

Bio
Wei Duan graduated from a medical school in Shanghai, China, and received the Ph.D. degree from the University of Melbourne, Parkville, Australia, in 1991.
He taught medicine and engaged in the research into molecular cell biology and novel therapeutics of cancer at the National University of Singapore. He is currently a Professor with Deakin Medical School, Waurn Ponds, Australia, where he heads a nanomedicine program to develop cancer-targeting aptamers and nanoparticles for cancer molecular imaging and targeted drug delivery.
Research Interests
Papers共 362 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Wei Duan,Rendy Hosea, Lingxian Wang,Cao Ruan, Fuqiang Zhao, Jingyi Liu,Hezhao Zhao,Makoto Miyagishi,Shourong Wu,Vivi Kasim
ADVANCED SCIENCE (2025)
Yizhen Jia, Xiaohan Kong,Rui Li,Han Wang, Chujie Li,Shihong Cheng,Wei Duan,Yan Xiao, Yang Mai,Wenbin Deng,Yang Liu
Journal of controlled release official journal of the Controlled Release Society (2025): 113781-113781
Shihong Cheng, Xiaohan Kong, Yiqiu Zhang, Jianing Gong,Han Wang,Wei Duan, Chujie Li, Xiyan Wang, Yan Xiao,Qiyue Wang,Yang Liu
Biomaterials (2025): 123516-123516
Rajindra Napit, Satendra Kumar Jaysawal,Rocky Chowdhury, Jasmine Catague, Haben Melke,Cuong Viet Pham,Huo Xu,Lee Jia,Jia Lin,Yingchu Hou,Wei Duan
Advanced Materials Technologies (2024)
openalex(2024)
BIOSENSORS & BIOELECTRONICS (2024)
Hongming Fang,Yujuan Zhou, Xue Bai, Wanlin Che, Wenxuan Zhang,Danying Zhang, Qingmei Chen,Wei Duan,Guochao Nie,Yingchun Hou
Load More
Author Statistics
#Papers: 358
#Citation: 21045
H-Index: 72
G-Index: 136
Sociability: 7
Diversity: 4
Activity: 50
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn